Presentation Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials Presenter: Raj Makkar October 31, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Aortic Valve Up Next Presentation Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease Presenter: Sunil V. Rao October 31, 2016 More slides + Presentation Next Generation MitraClip: Whats Better and Whats Not Presenter: Ted Feldman October 31, 2016 Presentation Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go Presenter: Emmanouil S. Brilakis October 31, 2016 We Recommend
Presentation Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease Presenter: Sunil V. Rao October 31, 2016
Presentation Next Generation MitraClip: Whats Better and Whats Not Presenter: Ted Feldman October 31, 2016
Presentation Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go Presenter: Emmanouil S. Brilakis October 31, 2016